west-nile-virus

Documents about west-nile-virus

• Treatment of West Nile Virus With MGAWN1#1101885ClinicalTrials.gov
• Safety Study of HBV-002 West Nile Vaccine in Healthy Adults#812107ClinicalTrials.gov
• West Nile Virus Seroprevalence Under Bird Ringers#1283204ClinicalTrials.gov
• Determinants of West Nile virus transmission in Miami-Dade County, Florida.#457761PubMed
• Hospitalizations associated with endemic and non-endemic mosquito-borne arboviruses in Canada, 2002–2023#10240PLOS
• West Nile virus: epidemiology, prevention, clinical features, diagnosis, treatment, and open research questions.#9764PubMed
• IVIG - West Nile Encephalitis: Safety and Efficacy#833632ClinicalTrials.gov
• Vector-borne disease surveillance and control resource needs in Colorado public health organizations#120215PLOS
• An Exploratory Study of AVI-4020 in Patients With Possible Acute Neuroinvasive West Nile Virus (WNV) Disease#1409072ClinicalTrials.gov
• Evaluation of the 2022 West Nile Virus Forecasting Challenge, USA#343929DigitalCommons@University of Nebraska
• Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4-3'delta30) in Healthy Adults#852421ClinicalTrials.gov
• Phase I Study of West Nile Virus Vaccine#1418250ClinicalTrials.gov
• Modulation of West Nile Virus Capsid Protein and Viral RNA Interaction through Phosphorylation#645123ScholarBank@NUS
• Protein Binding Sites and Cis-acting Sequences on the West Nile Virus 3' (+) SL RNA#492527ScholarWorks@GSU
• Phase 1 Trial of Inactivated West Nile Virus Vaccine#901895ClinicalTrials.gov
• Advances and Challenges in Vaccine Development for West Nile Virus (WNV) Infection#478652Europe PMC
• West Nile virus infection in the Mesopotamia region, Syria border of Turkey#954608Koc University Digital Collections
• Safety and Immunogenicity of an Inactivated West Nile Virus Vaccine in Healthy Adults#1465773ClinicalTrials.gov
• Développement de modèles d'infection 2D et 3D du système nerveux central par le virus West Nile et caractérisation de l'activité antivirale de différents composés chimiques#156061HAL (France)
• West Nile virus: epidemiology, prevention, clinical features, diagnosis, treatment, and open research questions#4731Europe PMC
• West Nile Virus: Seroprevalence and Epidemiological Study in Blood Donors in North Central Anatolia Amid Global Threats#5708Europe PMC
• Genomic epidemiology and phylogeographic reconstruction of West Nile virus 2 in Italy from 2011 to 2023#5329Europe PMC
• Catch basin larvicide treatments impact adult mosquito West Nile virus vector species in metropolitan Milwaukee, WI, U.S.A.#13956PLOS
• Infodemiology of West Nile Virus in Greece, 2024-2025, with Descriptive One Health Preparedness Evidence from Crete#642522Europe PMC
• Pesticide spraying for West Nile virus control and emergency department asthma visits in New York City, 2000#485700Harvard DASH
• Incorporating vertical transmission into mechanistic modeling of West Nile virus for optimized control in Germany#642547Europe PMC
• Shared viral burdens: Molecular evidence of Usutu virus infection and multi-arbovirus exposure in migrant and resident birds at wintering locations in Nigeria#469505PLOS
• West Nile Virus in Europe: Epidemiology, Vector Ecology, Environmental Drivers, and the Role of Equine Sentinel Surveillance in a One Health Framework#5831Europe PMC
• Mosquito feeding patterns in the context of West Nile and eastern equine encephalitis viruses in eastern Ontario, Canada.#434571PubMed
• Mortality dynamics of West Nile virus and Lyme disease in the United States : Temporal, spatial, and socioeconomic dimensions (2003–2021)#1390221Europe PMC
• Spatiotemporal and Demographic Patterns of West Nile Neuroinvasive Disease in Vojvodina, Serbia, 2012-2025#5826Europe PMC
• West Nile Virus Transmission Suitability Modeling for <i>Culex pipiens</i> via Temperature and Humidity#67617Europe PMC
• Tracking West Nile virus dynamics using viral loads from trapped mosquitoes#221571bioRxiv / medRxiv
• Ecologic Factors Contributing to West Nile Virus Hyperendemicity in Central South Carolina: An Integrated Vector–Human–Environmental Study#277885Scholar Commons
• Mosquitoes and their microbiota: Interactions with avian Plasmodium and West Nile virus#1347717Repositorio Institucional de la Universidad de Granada
• Ocular involvement in West Nile virus infection: a multimodal imaging study.#1519869NCBI PubMed Central
• Evaluating the ability of a thermal biology-informed reproduction number to explain patterns of West Nile incidence in Europe#273369Europe PMC
• Water availability has stronger effects on West Nile virus dynamics in water-limited regions#321452bioRxiv / medRxiv
• Triacylglycerol metabolism is a novel target to combat West Nile virus infection.#637078PubMed
• Septic Shock and Severe AKI Caused by West Nile Virus in Southern France#284283HAL (France)
• Investigating Visuo-spatial Abilities and Psychological Effects in West Nile and Multiple Sclerosis Patients with a Focus on a Possible Rehabilitation Protocol#1484893ClinicalTrials.gov
• An Explainable Machine Learning Framework for Predicting West Nile Virus and Uncovering Key Transmission Drivers.#785652NCBI PubMed Central
• A Critical Role for Induced IgM in the Protection against West Nile Virus Infection#403260OpenAlex
• Modelling the impact of temperature and bird migration on the spread of West Nile virus.#9780PubMed
• West Nile Virus among Hospitalized, Febrile Patients: A Case for Expanding Diagnostic Testing#384113CiNii
• Constraint in West Nile virus envelope protein across mosquito, human, and avian host cell environments.#1519860NCBI PubMed Central
• Climate-driven modelling of the spread and control of West Nile virus and Usutu virus in Germany / Pride Duve ; Betreuer: Jonas Schmidt-Chanasit#1341059Deutsche Nationalbibliothek
• Fine-scale heterogeneity and local amplification of West Nile virus in urban environments in Berlin#307877Europe PMC
• Underrecognized Tick-Borne Encephalitis in Serbia: Evidence from Patients with Suspected West Nile Virus Neuroinvasive Disease#445617HAL (France)
• Pharmacokinetic Study in Cerebral Spinal Fluid After a Single Dose of AVI-4020#1420001ClinicalTrials.gov